Takeda Pharmaceutical Company Limited (4502.T)
JPY 4093.0
(-0.1%)
JPY 4093.0
(-0.1%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 4476.5 Billion JPY | 10.73% |
| 2022 | 4042.74 Billion JPY | -2.38% |
| 2021 | 4141.41 Billion JPY | -10.23% |
| 2020 | 4613.21 Billion JPY | 2.37% |
| 2019 | 4506.48 Billion JPY | -5.45% |
| 2018 | 4766 Billion JPY | 383.54% |
| 2017 | 985.64 Billion JPY | 64.31% |
| 2016 | 599.86 Billion JPY | 11.13% |
| 2015 | 539.76 Billion JPY | -14.24% |
| 2014 | 629.41 Billion JPY | -10.67% |
| 2013 | 704.58 Billion JPY | 26.72% |
| 2012 | 556.01 Billion JPY | 74.92% |
| 2011 | 317.86 Billion JPY | 1999.89% |
| 2010 | 15.13 Billion JPY | -2.46% |
| 2009 | 15.51 Billion JPY | -6.23% |
| 2008 | 16.55 Billion JPY | 1224.0% |
| 2007 | 1.25 Billion JPY | -39.02% |
| 2006 | 2.05 Billion JPY | -40.97% |
| 2005 | 3.47 Billion JPY | -37.55% |
| 2004 | 5.56 Billion JPY | 19.31% |
| 2003 | 4.66 Billion JPY | -4.21% |
| 2002 | 4.86 Billion JPY | -11.4% |
| 2001 | 5.49 Billion JPY | -17.43% |
| 2000 | 6.65 Billion JPY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 5042.24 Billion JPY | 12.64% |
| 2024 Q2 | 4427.09 Billion JPY | -12.2% |
| 2023 Q1 | 4330.25 Billion JPY | 7.11% |
| 2023 Q4 | 4476.5 Billion JPY | 4.25% |
| 2023 Q2 | 4404.36 Billion JPY | 1.71% |
| 2023 Q3 | 4293.87 Billion JPY | -2.51% |
| 2023 FY | 4476.5 Billion JPY | 10.73% |
| 2022 Q1 | 4320.35 Billion JPY | 4.32% |
| 2022 Q4 | 4042.74 Billion JPY | 3.27% |
| 2022 Q3 | 3914.88 Billion JPY | -6.08% |
| 2022 Q2 | 4168.41 Billion JPY | -3.52% |
| 2022 FY | 4042.74 Billion JPY | -2.38% |
| 2021 Q4 | 4141.41 Billion JPY | -2.14% |
| 2021 Q2 | 4016.47 Billion JPY | -8.33% |
| 2021 Q1 | 4381.58 Billion JPY | -5.02% |
| 2021 FY | 4141.41 Billion JPY | -10.23% |
| 2021 Q3 | 4231.93 Billion JPY | 5.36% |
| 2020 FY | 4613.21 Billion JPY | 2.37% |
| 2020 Q1 | 4494.22 Billion JPY | -0.27% |
| 2020 Q2 | 4631.41 Billion JPY | 3.05% |
| 2020 Q3 | 4466.57 Billion JPY | -3.56% |
| 2020 Q4 | 4613.21 Billion JPY | 3.28% |
| 2019 FY | 4506.48 Billion JPY | -5.45% |
| 2019 Q3 | 4610.05 Billion JPY | -5.01% |
| 2019 Q2 | 4853.21 Billion JPY | -5.43% |
| 2019 Q1 | 5131.98 Billion JPY | 7.68% |
| 2019 Q4 | 4506.48 Billion JPY | -2.25% |
| 2018 Q4 | 4766 Billion JPY | 96.29% |
| 2018 Q3 | 2428.04 Billion JPY | 176.03% |
| 2018 Q2 | 879.62 Billion JPY | -11.49% |
| 2018 Q1 | 993.78 Billion JPY | 0.83% |
| 2018 FY | 4766 Billion JPY | 383.54% |
| 2017 Q1 | 941.21 Billion JPY | 56.9% |
| 2017 FY | 985.64 Billion JPY | 64.31% |
| 2017 Q4 | 985.64 Billion JPY | -1.28% |
| 2017 Q3 | 998.46 Billion JPY | 0.11% |
| 2017 Q2 | 997.36 Billion JPY | 5.97% |
| 2016 Q2 | 739.79 Billion JPY | 0.0% |
| 2016 Q4 | 599.86 Billion JPY | -18.94% |
| 2016 Q3 | 740.05 Billion JPY | 0.03% |
| 2016 Q1 | 739.77 Billion JPY | 37.06% |
| 2016 FY | 599.86 Billion JPY | 11.13% |
| 2015 FY | 539.76 Billion JPY | -14.24% |
| 2015 Q4 | 539.76 Billion JPY | -14.34% |
| 2015 Q3 | 630.12 Billion JPY | 0.17% |
| 2015 Q2 | 629.04 Billion JPY | -0.65% |
| 2015 Q1 | 633.18 Billion JPY | 0.6% |
| 2014 Q3 | 731.08 Billion JPY | 2.28% |
| 2014 FY | 629.41 Billion JPY | -10.67% |
| 2014 Q1 | 702.55 Billion JPY | -0.29% |
| 2014 Q2 | 714.76 Billion JPY | 1.74% |
| 2014 Q4 | 629.41 Billion JPY | -13.91% |
| 2013 Q4 | 704.58 Billion JPY | -10.82% |
| 2013 FY | 704.58 Billion JPY | 26.72% |
| 2013 Q3 | 790.08 Billion JPY | -0.0% |
| 2013 Q2 | 790.08 Billion JPY | 46.28% |
| 2013 Q1 | 540.12 Billion JPY | -2.86% |
| 2012 FY | 556.01 Billion JPY | 74.92% |
| 2012 Q1 | 301.34 Billion JPY | -5.19% |
| 2012 Q4 | 556.01 Billion JPY | 2.93% |
| 2012 Q2 | 540.29 Billion JPY | 79.29% |
| 2012 Q3 | 540.2 Billion JPY | -0.02% |
| 2011 Q2 | - JPY | 0.0% |
| 2011 FY | 317.86 Billion JPY | 1999.89% |
| 2011 Q3 | - JPY | 0.0% |
| 2011 Q1 | - JPY | -100.0% |
| 2011 Q4 | 317.86 Billion JPY | 0.0% |
| 2010 Q4 | 15.13 Billion JPY | 0.0% |
| 2010 Q1 | - JPY | -100.0% |
| 2010 Q2 | - JPY | 0.0% |
| 2010 Q3 | - JPY | 0.0% |
| 2010 FY | 15.13 Billion JPY | -2.46% |
| 2009 Q2 | - JPY | 0.0% |
| 2009 FY | 15.51 Billion JPY | -6.23% |
| 2009 Q4 | 15.51 Billion JPY | 0.0% |
| 2009 Q3 | - JPY | 0.0% |
| 2008 FY | 16.55 Billion JPY | 1224.0% |
| 2008 Q3 | - JPY | 0.0% |
| 2008 Q4 | 16.55 Billion JPY | 0.0% |
| 2007 FY | 1.25 Billion JPY | -39.02% |
| 2006 FY | 2.05 Billion JPY | -40.97% |
| 2005 FY | 3.47 Billion JPY | -37.55% |
| 2004 FY | 5.56 Billion JPY | 19.31% |
| 2003 FY | 4.66 Billion JPY | -4.21% |
| 2002 FY | 4.86 Billion JPY | -11.4% |
| 2001 FY | 5.49 Billion JPY | -17.43% |
| 2000 FY | 6.65 Billion JPY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 1.23 Billion JPY | -363547.522% |
| Sumitomo Pharma Co., Ltd. | 133.36 Billion JPY | -3256.528% |
| Shionogi & Co., Ltd. | 8.75 Billion JPY | -51042.477% |
| Wakamoto Pharmaceutical Co.,Ltd. | - JPY | -Infinity% |
| Nippon Shinyaku Co., Ltd. | 1.15 Billion JPY | -388485.156% |
| Kaken Pharmaceutical Co., Ltd. | - JPY | -Infinity% |
| Eisai Co., Ltd. | 134.77 Billion JPY | -3221.512% |
| Morishita Jintan Co., Ltd. | 106 Million JPY | -4223014.151% |
| Hisamitsu Pharmaceutical Co., Inc. | 76 Million JPY | -5890032.895% |
| Mochida Pharmaceutical Co., Ltd. | - JPY | -Infinity% |
| Fuso Pharmaceutical Industries,Ltd. | 7.02 Billion JPY | -63658.738% |
| Nippon Chemiphar Co., Ltd. | 13.34 Billion JPY | -33446.92% |
| Tsumura & Co. | 54.37 Billion JPY | -8132.343% |
| Kissei Pharmaceutical Co., Ltd. | - JPY | -Infinity% |
| Torii Pharmaceutical Co., Ltd. | 22 Million JPY | -20347631.818% |
| Towa Pharmaceutical Co., Ltd. | 189.12 Billion JPY | -2266.966% |
| Fuji Pharma Co., Ltd. | 11.92 Billion JPY | -37441.941% |
| Zeria Pharmaceutical Co., Ltd. | 7.94 Billion JPY | -56252.136% |
| KYORIN Holdings, Inc. | 435 Million JPY | -1028980.69% |
| Taiko Pharmaceutical Co.,Ltd. | 2.74 Billion JPY | -163216.344% |
| Daito Pharmaceutical Co.,Ltd. | 4.66 Billion JPY | -95777.083% |
| SymBio Pharmaceuticals Limited | - JPY | -Infinity% |
| MedRx Co., Ltd | - JPY | -Infinity% |
| Mizuho Medy Co.,Ltd. | - JPY | -Infinity% |
| Solasia Pharma K.K. | 27 Million JPY | -16579533.333% |
| Modalis Therapeutics Corporation | 412.5 Million JPY | -1085112.364% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 4.5 Billion JPY | -99267.392% |
| Sawai Group Holdings Co., Ltd. | 66.84 Billion JPY | -6597.238% |
| Cyfuse Biomedical K.K. | 345 Million JPY | -1297436.522% |
| Toho Holdings Co., Ltd. | 28.16 Billion JPY | -15793.279% |
| Koa Shoji Holdings Co.,Ltd. | 1.59 Billion JPY | -281196.092% |